ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Chronic Renal Insufficiency
Kidney Diseases
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Insufficiency
Renal Cell Carcinoma
Kidney Cancer

Kidney Disease trials near Roma, Lazio, ITA:

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...

Enrolling
Autosomal Dominant Polycystic Kidney Disease
Drug: ABBV-CLS-628
Drug: Placebo

Phase 2

Calico Life Sciences
Calico Life Sciences

Rome, Roma, Italy and 92 other locations

with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Part...

Enrolling
Chronic Kidney Disease
Atherosclerosis Cardiovascular Disease
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Roma, Italy and 560 other locations

This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compare...

Not yet enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Elecoglipron

Phase 3

AstraZeneca
AstraZeneca

Rome, Italy and 425 other locations

to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...

Active, not recruiting
Chronic Kidney Disease With High Proteinuria
Drug: Dapagliflozin
Drug: Zibotentan/Dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 297 other locations

This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Empagliflozin

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Roma, Italy and 98 other locations

Locations recently updated

and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...

Enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Placebo/dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 757 other locations

of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...

Active, not recruiting
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Roma, Italy and 762 other locations

disease (ASCVD) or diabetes with end stage kidney disease (ESKD) undergoing maintenance dialysis....

Enrolling
End Stage Kidney Disease
Drug: Placebo
Drug: CSL300

Phase 2, Phase 3

CSL Behring
CSL Behring

Rome, Italy and 555 other locations

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take p...

Enrolling
Kidney Disease, Chronic
Drug: Placebo matching BI 690517
Drug: BI 690517

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Roma, Italy and 516 other locations

AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease...

Active, not recruiting
Diabetic Kidney Disease
Immunoglobulin A Nephropathy
Drug: Atrasentan

Phase 2

Novartis
Novartis

Roma, RM, Italy and 38 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems